Clinical Trial Update: Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a dexamethasone intravitreal implant (Ozurdex) for diabetic macular edema with hard exudates; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Inje University | Conditions: Diabetes Mellitus, Macular Edema | Phase 4 | Status: UNKNOWN